EQS-News: Immunic, Inc.: Immunic Completes Enrollment of Its

EQS-News: Immunic, Inc.: Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

EQS-News: Immunic, Inc.: Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Ukraine , Russia , United States , America , Edna Kaplan , Paula Schwartz , Daniel Vitt , Andreas Muehler , Jessica Breu , Nasdaq , Immunic Inc , Exchange Commission , Rx Communications Group , Distribution Services , Completes Enrollment , Its Phase , Vidofludimus Calcium , Progressive Multiple Sclerosis , Progressive Multiple , Interim Biomarker Analysis Expected , Data Readout Expected , Chief Executive Officer , Chief Medical Officer , North America , Eastern Europe , Private Securities Litigation Reform Act , Annual Report , Investor Relations , Corporate News , Regulatory Announcements , Aktien Sie ,